RARX
Legal & General Group’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-21,823
| Closed | -$1.05M | – | 3565 |
|
|
2020
Q1 | $1.05M | Buy |
21,823
+11,153
| +105% | +$536K | ﹤0.01% | 1838 |
|
|
2019
Q4 | $500K | Buy |
10,670
+4,223
| +66% | +$198K | ﹤0.01% | 2218 |
|
|
2019
Q3 | $152K | Buy |
6,447
+569
| +10% | +$13.4K | ﹤0.01% | 2414 |
|
|
2019
Q2 | $177K | Buy |
5,878
+2,153
| +58% | +$64.8K | ﹤0.01% | 2378 |
|
|
2019
Q1 | $84K | Buy |
3,725
+662
| +22% | +$14.9K | ﹤0.01% | 2545 |
|
|
2018
Q4 | $56K | Buy |
3,063
+1,121
| +58% | +$20.5K | ﹤0.01% | 2655 |
|
|
2018
Q3 | $35K | Hold |
1,942
| – | – | ﹤0.01% | 2960 |
|
|
2018
Q2 | $19K | Sell |
1,942
-1,015
| -34% | -$9.93K | ﹤0.01% | 3206 |
|
|
2018
Q1 | $16K | Sell |
2,957
-301
| -9% | -$1.63K | ﹤0.01% | 3153 |
|
|
2017
Q4 | $28K | Hold |
3,258
| – | – | ﹤0.01% | 3089 |
|
|
2017
Q3 | $48K | Hold |
3,258
| – | – | ﹤0.01% | 2923 |
|
|
2017
Q2 | $63K | Buy |
3,258
+2,013
| +162% | +$38.9K | ﹤0.01% | 2837 |
|
|
2017
Q1 | $27K | Hold |
1,245
| – | – | ﹤0.01% | 3009 |
|
|
2016
Q4 | $19K | Buy |
+1,245
| New | +$19K | ﹤0.01% | 3127 |
|